JJIJ
CALC icon

Johnson & Johnson Innovation - JJDC’s CalciMedica CALC Stock Holding History

Johnson & Johnson Innovation - JJDC’s Portfolio CALC Stock Details CALC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		$269K Hold
3,539
– – 0.03% 19
2021
Q1 		$275K Buy
+3,539
New +$1.06M 0.04% 16

Other funds holding CALC

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Johnson & Johnson Innovation - JJDC's CALC Position: Q2 2021 in Review

Johnson & Johnson Innovation - JJDC held its CalciMedica (CALC) position steady in Q2 2021 at 3,539 shares worth $269K. The position accounts for 0.03% of the portfolio, ranked #19.

Johnson & Johnson Innovation - JJDC first reported a position in CALC in Q1 2021 and has held it in 2 quarters since. The position peaked at $275K in Q1 2021. 41 funds tracked by Wall St. Rank hold CALC as of Q2 2021.

  • Johnson & Johnson Innovation - JJDC held 3,539 shares of CalciMedica worth $269K as of Q2 2021.
  • Johnson & Johnson Innovation - JJDC left its CalciMedica share count unchanged in Q2 2021.
  • CalciMedica made up 0.03% of Johnson & Johnson Innovation - JJDC's portfolio in Q2 2021, its #19 holding.
  • Johnson & Johnson Innovation - JJDC first reported a position in CalciMedica in Q1 2021 and has held it in 2 quarters since.
  • Johnson & Johnson Innovation - JJDC's CalciMedica position peaked at $275K in Q1 2021.
  • 41 funds tracked by Wall St. Rank held CalciMedica as of Q2 2021.

Based on Johnson & Johnson Innovation - JJDC's 13F filing for Q2 2021, filed 3 Aug 2021.